DANGER OF MAOI THERAPY AFTER FLUOXETINE WITHDRAWAL

The Lancet

Volumn 332, Issue 8615, 1988, Pages 850-851

  Sternbach, Harvey ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; MONOAMINE OXIDASE INHIBITOR;

ADULT; ANXIETY; CASE REPORT; DEPRESSION; DRUG THERAPY; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT;

ADULT; CASE REPORT; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; FEMALE; FLUOXETINE; HUMAN; SUBSTANCE WITHDRAWAL SYNDROME; TRANYLCYPROMINE;

EID: 0023782215     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(88)92812-7     Document Type: Letter

References (3)

1. Case report of a toxic reaction from a combination of tryptophan and phenelzine
2. MAOIs plus tryptophan. a cause of the serotonin syndrome
3. NMS sans neuroleptics? The limits of syndromal classification